By Dhirendra TripathiInvesting.com -- Stocks rose on Tuesday on strong results from Johnson & Johnson and others that whet investors’ risk appetites.The S&P 500 was...
By Yasin EbrahimInvesting.com – The S&P 500 advanced Tuesday, as rising health care stocks and an Apple-led jump in tech underpinned bullish bets on the broader market.The S&P...
Johnson & Johnson (NYSE: JNJ) shares are higher Tuesday following the release of its third-quarter results.J&J A Bellwether For The Sector: Given the timing of J&J's earnings...
US stocks ended higher on Friday, with the benchmark S&P 500 index scoring its best weekly performance since June thanks to a strong start to the third quarter earnings season...
The stocks of the vaccine producers have gained a lot during 2021 due to the wide vaccination campaign around the world. Still, the COVID-19 pandemic is still not over as the virus...
FDA Hints J&J Booster Jab May Be Beneficial, But Remains Mum On Approval OddsWith just one day left before the FDA's vaccine advisory committee meets in person to discuss...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Neutral | Buy |
| Technical Indicators | Strong Buy | Sell | Strong Buy | Sell | Buy |
| Summary | Strong Buy | Neutral | Strong Buy | Neutral | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 432.10 | 434.10 | 430.00 | -0.70 | -0.16% | 15.77M | London | |||
| 33.38 | 33.62 | 33.08 | +0.30 | +0.91% | 4.06M | London | |||
| 198.60 | 205.50 | 196.60 | -2.40 | -1.19% | 294.66K | London | |||
| 372.80 | 377.20 | 367.60 | +3.40 | +0.92% | 475.67K | London | |||
| 321.60 | 329.20 | 320.40 | -8.40 | -2.54% | 201.81K | London | |||
| 3,885.00 | 3,905.00 | 3,825.00 | -5.0 | -0.13% | 23.43K | London | |||
| 373.60 | 398.60 | 373.00 | -21.20 | -5.37% | 1.14M | London | |||
| 317.60 | 328.80 | 315.80 | -4.40 | -1.37% | 1.09M | London | |||
| 52.08 | 53.04 | 51.18 | +0.46 | +0.89% | 7.70M | London | |||
| 64.74 | 65.72 | 64.58 | -0.18 | -0.28% | 3.23M | London | |||
| 49.40 | 49.48 | 49.00 | +0.12 | +0.25% | 113.21M | London | |||
| 880.00 | 884.00 | 878.00 | +2.00 | +0.23% | 370.90K | London | |||
| 5,050.00 | 5,098.00 | 5,006.00 | +48.0 | +0.96% | 2.73M | London | |||
| 342.00 | 354.00 | 341.00 | -10.00 | -2.84% | 84.24K | London | |||
| 1,079.00 | 1,080.00 | 1,078.00 | 0.00 | 0.00% | 0.00 | London |
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.